Cardio-respiratory and other symptom clusters in panic disorder.
Bandelow
B
B
Department of Psychiatry, University of Göttingen, Germany.
Amering
M
M
Benkert
O
O
Marks
I
I
Nardi
A E
AE
Osterheider
M
M
Tannock
C
C
Tremper
J
J
Versiani
M
M
D000328:Adult; D000379:Agoraphobia / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D001570:Benzodiazepinones / Q000009:adverse effects / Q000627:therapeutic use; D004311:Double-Blind Method; D004417:Dyspnea / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology*; D005260:Female; D006801:Humans; D006985:Hyperventilation / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology*; D008297:Male; D008875:Middle Aged; D009449:Neurocirculatory Asthenia / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology*; D016584:Panic Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology*; D013001:Somatoform Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology*
D000927:Anticonvulsants; D001570:Benzodiazepinones; C054626:bretazenil